Uncommon

Cambridge, United Kingdom Founded: 2017 • Age: 9 yrs Acquired By Meatable
High-quality pork products are produced from healthy pork cells.
Request Access

About Uncommon

Uncommon is a company based in Cambridge (United Kingdom) founded in 2017 by Benjamina Bollag and Ruth Faram was acquired by Meatable in August 2025. It operates as a HealthTech. Uncommon has raised $30 million across 1 funding round from investors including Meatable, Balderton Capital and Redalpine. Uncommon offers products and services including SymphoRNA. Uncommon operates in a competitive market with competitors including ENOUGH, VFC Foods, Ivy Farm, Adamo Foods and Roslin Technologies, among others.

  • Headquarter Cambridge, United Kingdom
  • Founders Benjamina Bollag, Ruth Faram
  • Sectors
    Consumer
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Consumer → Food, Beverage & Nutrition
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $30 M (USD)

    in 1 rounds

  • Latest Funding Round
    $30 M (USD), Series A

    Jun 09, 2023

  • Investors
    Meatable

    & 6 more

  • Employee Count
    Employee Count
  • Acquired by
    Meatable

    (Aug 21, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Uncommon

Uncommon offers a comprehensive portfolio of products and services, including SymphoRNA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

A platform for nucleic acid delivery technology.

Funding Insights of Uncommon

Uncommon has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Series A round of $30 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $30.0M
  • First Round

    (09 Jun 2023)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2023 Amount Series A - Uncommon Valuation Balderton Capital , Lowercarbon Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Uncommon

Uncommon has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Meatable, Balderton Capital and Redalpine. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Early-stage investments are directed toward ICT and health tech startups.
Founded Year Domain Location
Multistage venture capital investments are focused on technology sectors.
Founded Year Domain Location
Venture capital fund focused on tech startups
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Uncommon

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Uncommon

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Uncommon Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Uncommon

Uncommon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ENOUGH, VFC Foods, Ivy Farm, Adamo Foods and Roslin Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Fungi-based meat substitutes are developed under the ENOUGH brand.
domain founded_year HQ Location
Provider of plant-based food products to replace meat
domain founded_year HQ Location
Cultivated plant-based meat products are developed by Ivy Farm.
domain founded_year HQ Location
Fungi-based meat substitute products are developed by Adamo Foods.
domain founded_year HQ Location
Livestock biotechnology solutions for avian species are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Uncommon

Frequently Asked Questions about Uncommon

When was Uncommon founded?

Uncommon was founded in 2017 and raised its 1st funding round 6 years after it was founded.

Where is Uncommon located?

Uncommon is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Who is the current CEO of Uncommon?

Benjamina Bollag is the current CEO of Uncommon. They have also founded this company.

Is Uncommon a funded company?

Uncommon is a funded company, having raised a total of $30M across 1 funding round to date. The company's 1st funding round was a Series A of $30M, raised on Jun 09, 2023.

What does Uncommon do?

Uncommon is engaged in developing advanced nucleic acid delivery technology through its SymphoRNA platform. The company has transitioned from its previous cultivated platform, which was sold to Vow and Meatable, to focus on innovative solutions in the biotechnology sector. Its efforts are directed towards creating impactful health technology solutions.

Who are the top competitors of Uncommon?

Uncommon's top competitors include Quorn Foods, Roslin Technologies and ENOUGH.

What products or services does Uncommon offer?

Uncommon offers SymphoRNA.

Who are Uncommon's investors?

Uncommon has 7 investors. Key investors include Meatable, Balderton Capital, Redalpine, East Alpha, and Lowercarbon Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available